Canada Contrast and Imaging Agents in Interventional X-ray Market Industry Trends and Forecast to 2026

TABLE OF CONTENTS

1 INTRODUCTION 9

• 1.1 OBJECTIVES OF THE STUDY 9
• 1.2 MARKET DEFINITION 9
• 1.3 OVERVIEW OF CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET 9
• 1.4 CURRENCY AND PRICING 10
• 1.5 LIMITATION 11
• 1.6 MARKETS COVERED 11

2 MARKET SEGMENTATION 12

• 2.1 MARKETS COVERED 12
• 2.2 YEARS CONSIDERED FOR THE STUDY 13
• 2.3 CURRENCY AND PRICING 13
• 2.4 RESEARCH METHODOLOGY 14
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 17
• 2.6 DBMR MARKET CHALLENGE MATRIX 18
• 2.7 MARKET APPLICATION COVERAGE GRID 19
• 2.8 DBMR VENDOR SHARE ANALYSIS 20
• 2.9 SECONDARY SOURCES 21
• 2.10 ASSUMPTIONS 21

3 MARKET OVERVIEW 22

• 3.1 DRIVERS 24
  • 3.1.1 RISING NUMBER OF CHRONIC DISEASES 24
  • 3.1.2 RISING AGING POPULATION 24
  • 3.1.3 GROWING NUMBER OF DIAGNOSTIC CENTERS 25
  • 3.1.4 INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS 26
• 3.2 RESTRAINTS 28
  • 3.2.1 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS. 28
• 3.3 OPPORTUNITIES 28
  • 3.3.1 RISING HEALTHCARE EXPENDITURE 28
  • 3.3.2 INCREASE IN NUMBER OF PUBLIC AND PRIVATE HOSPITALS 30
• 3.4 CHALLENGES 31
  • 3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT 31

4 EXECUTIVE SUMMARY 32

5 PREMIUM INSIGHTS 34

6 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE 36

• 6.1 OVERVIEW 37
• 6.2 IODINATED CONTRAST MEDIA 38
• 6.3 BARIUM-BASED CONTRAST MEDIA 38
• 6.4 MICROBUBBLE CONTRAST MEDIA 38
• 6.5 GOLD NANOPARTICLE CONTRAST AGENTS 38
• 6.6 OTHERS 38

7 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION 39

• 7.1 OVERVIEW 40
• 7.2 CARDIOLOGY 42
  • 7.2.1 PERCUTANEOUS CORONARY INTERVENTION 42
  • 7.2.2 STRUCTURAL HEART DISEASE 42
  • 7.2.3 CONGENITAL HEART DISEASE 42
  • 7.2.4 ELECTROPHYSIOLOGY 42
• 7.3 GASTROENTEROLOGY 42
• 7.4 NEUROLOGY 43
• 7.5 ONCOLOGY 43
• 7.6 UROLOGY 43
• 7.7 GENERAL SURGERY 43

8 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER 44

• 8.1 OVERVIEW 45
• 8.2 IMAGING CENTERS 46
• 8.3 HOSPITAL 46
• 8.4 CLINICS 46
• 8.5 DIAGNOSTIC CENTER 46
• 8.6 AMBULATORY SURGICAL CENTERS 46
• 8.7 PRIVATE PRACTICES 46

9 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE 47

• 9.1 COMPANY SHARE ANALYSIS: CANADA 47

10 COMPANY PROFILES 48

• 10.1 GENERAL ELECTRIC COMPANY 48
  • 10.1.1 COMPANY SNAPSHOT 48
  • 10.1.2 REVENEUE ANALYSIS 48
  • 10.1.3 PRODUCT PORTFOLIO 49
  • 10.1.4 RECENT DEVELOPMENTS 49
• 10.2 BRACCO 50
  • 10.2.1 COMPANY SNAPSHOT 50
  • 10.2.2 GEOGRAPHICAL PRESENCE 50
  • 10.2.3 PRODUCT PORTFOLIO 51
  • 10.2.4 RECENT DEVELOPMENTS 52
• 10.3 LANTHEUS MEDICAL IMAGING, INC. 53
  • 10.3.1 COMPANY SNAPSHOT 53
  • 10.3.2 REVENUE ANALYSIS 53
  • 10.3.3 PRODUCT PORTFOLIO 54
  • 10.3.4 RECENT DEVELOPMENTS 54
• 10.4 GUERBET 55
  • 10.4.1 COMPANY SNAPSHOT 55
  • 10.4.2 REVENEUE ANALYSIS 55
  • 10.4.3 PRODUCT PORTFOLIO 56
  • 10.4.4 RECENT DEVELOPMENTS 56
• 10.5 57
• 10.6 FUJIFILM VISUALSONICS INC. 57
  • 10.6.1 COMPANY SNAPSHOT 57
  • 10.6.2 GEOGRAPHICAL PRESENCE 57
  • 10.6.3 PRODUCT PORTFOLIO 58
  • 10.6.4 RECENT DEVELOPMENT 58

11 RELATED REPORTS 59

12 QUESTIONNAIRE 63